Transforming growth factor-β boosts the functionality of human bone marrow-derived mesenchymal stromal cells.
Vaijayanti P KalePublished in: Cell biology international (2020)
Transforming growth factor β1 (TGFβ1) is a negative regulator of hematopoiesis, and yet, it is frequently found at the active sites of hematopoiesis. Here, we show for the first time that bone marrow-derived mononuclear cells (BM MNCs) secrete TGFβ1 in response to erythropoietin (EPO). We further show that human bone marrow-derived mesenchymal stromal cells (BMSCs) briefly exposed to the conditioned medium of EPO-primed MNCs, or purified TGFβ1, gain significantly increased hematopoiesis-supportive ability. Mechanistically, we show that this phenomenon involves TGFβ1-mediated activation of nitric oxide (NO) signalling pathway in the BMSCs. The data suggest that EPO-MNC-TGFβ1 could be one of the regulatory axes operative in the bone marrow microenvironment involved in maintaining the functionality of the resident BMSCs.
Keyphrases
- transforming growth factor
- epithelial mesenchymal transition
- bone marrow
- mesenchymal stem cells
- endothelial cells
- nitric oxide
- induced apoptosis
- transcription factor
- induced pluripotent stem cells
- signaling pathway
- pluripotent stem cells
- patient safety
- hydrogen peroxide
- cell cycle arrest
- big data
- quality improvement
- endoplasmic reticulum stress
- pi k akt